InnerVision was founded in 2002 with a mandate to improve healthcare through 'world-changing' biomedical diagnosis tools. This is to be achieved with breakthrough acoustic technology, and a business model that is simultaneously cost effective for the health care system, and profitable for InnerVision.

InnerVision Medical Technologies Inc. is a privately held technology company engaged in the research, development and commercialization of an ultra high resolution, instant-capture, acoustic based imaging system. This technology is called Flash Ultrasound™. We believe Flash Ultrasound™ is a significant scientific breakthrough which combines novel techniques in acoustic wave analysis and the computational power of new age super computing.

The system is a platform technology initially being developed for medical applications: specifically for the screening diagnosis of breast cancer and prostate cancer carotid artery imaging; deep anatomical targets as well as imaging applications in pharmaceutical research and development. Visit the Medical Applications section for more information.

In addition to medical applications, the technology is applicable in the non-destructive testing and industrial measurement fields.

InnerVision's Board and Management are the principle investors in the company, and are stewarding InnerVision towards commercializing its technology.